Disclaimer: This article was published in 2021 and reflects the information available at that time.
  Vaccinating pharmacists take note… The Moderna Spikevax vaccine has been approved as a booster dose over the weekend with a different dose volume to the primary vaccination course. The ATAGI statement on Moderna as a booster outlines the arrangements for Moderna booster doses and indicates the below: The Moderna Spikevax booster vaccination is authorised for all patients aged 18 years and older, including pregnant women. The dose for the Moderna Spikevax vaccine as a booster is 0.25mL (50µg), which is half the recommended dosage of the Moderna vaccine …

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

What pharmacists need to know about the new intranasal flu vaccine (FluMist®)
4 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more